NIFTY
90.20  0.95% 		 9580.30
S&P BSE SENSEX
223.51  0.69% 		 32424.1
Divis Laboratories Ltd.
NSE : DIVISLAB BSE : 532488 ISIN code : INE361B01024
on 29-May-2020
NSE
105    4.59%
Rs. 2390.10
 
Days Low
Rs. 2265.05 		Days High
Rs. 2409.35

Open Rs. 2299
 
52 week Low
Rs. 1466.95 		52 week High
Rs.2473.65
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.2395.75
112.3    4.92%
on 29-May-2020
BSE
112.3    4.92%
Rs. 2395.75
 
Days Low
Rs. 2262.3 		Days High
Rs. 2408.1

Open Rs. 2285
 
52 week Low
Rs. 1466 		52 week High
Rs.2474.45
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.2390.10
105    4.59%
Summary Company Information Fund Holdings
Chart Display Advance Chart
Profit & Loss Balance Sheet Cash Flow Financial Ratios Quarterly Results
 
 
Last Price (Rs.)  2395.75 Value  54283636.00
Net Change (Rs.)  112.30 Best Buy  0.00
Volume  23030 Best Sell  0.00
Prev.Close (Rs.)  2283.45 Best Quantity  0
Open (Rs.)  2299.00 Sell Quantity  0
High (Rs.)  2409.35 52-Week High (Rs.)  2473.65
Low (Rs.)  2265.05 52-Week Low (Rs.)  1466.95
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  635996.35
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital530.90 530.90 530.90 
Share Capital530.90 530.90 530.90 
Share Capital530.90 530.90 530.90 
Share Capital530.90 530.90 530.90 
Share Capital530.90 530.90 530.90 
Currents Investments13983.40 18892.90 16307.20 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 475.45 1140764 105.10 139.69 0.58
Dr. Reddys Lab 4073.80 676952 914.23 52.94 0.61
Cipla 647.60 522121 215.85 27.63 0.46
Aurobindo Pharma 745.05 436554 213.23 28.54 0.34
Biocon 354.70 425640 62.81 43.19 0.28
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2019Sep 2019Jun 2019
Net Sales13904.9014039.2011399.20
Operating Profit5371.805327.204102.40
PBDT5356.305289.304099.20
Net Profit3607.303528.302673.50
More> 
 
Company News
3/9/2020 12:00:00 AM
Intimation Of Commencement Of Commercial Production From DCV-SEZ Unit
3/9/2020 12:00:00 AM
Divi’s Laboratories starts commercial production from DCV-SEZ Unit in ...
3/9/2020 12:00:00 AM
Divis Laboratories informs about commencement of commercial production...
More>
 
Ratios
   Earnings Per Share (Rs)50.20 
   Book NAV/Share(Rs)262.70 
   PAT Margin (%)27.31 
   Asset Turnover(x)0.57 
   PER(x)33.93 
   Yield(%)0.94 
   EV/Core EBITDA(x)22.53 
   M Cap / Sales9.27 
   Net Sales Growth(%)27.88 
   PAT Growth(%)53.25 
   Total Debt/Equity(x)0.02 
   Current Ratio(x)5.58 
   Quick Ratio(x)3.58 
   Total Debt/Mcap(x)0.00 
More>
 
Privacy Statement  |  Disclaimer  |  Terms of Use   |  Careers  |  Feedback  |   Terms and Conditions  |  Anti Money Laundering Measures  |  Important Policies   |  Dos & Donts   |   BSE  |   NSE  |   SEBI   |   SEBI Scores  |   NCDEX  |   NSDL  |   CDSL  |   RBI  |   AMFI  |   Ministry of Finance  |   Government of India
Copyright © 2012, Khandwala Securities Limited MAPIN UIN100012369, NSE INF2306000030, BSE INB010600030, NCDEX: NCDEX-CO-05-00506, AMFI ARN: 1673, Certificate of Registration as Portfolio Manager INP000000340, Certificate of Registration as Merchant Banking – INM000001899, SEBI Registration No. INB 230600030 (NSE) INB 010600030 (BSE)
For Investor Grievance please mail to: :investorgrievances@kslindia.com
CIN NO. : L67120MH1993PLC070709
Designed, Developed & Content Powered by  ● ● ● Accord Fintech Pvt. Ltd    Best viewed in internet Explorer 7.0 or above